Skip to main content
Erschienen in: Journal of Diabetes & Metabolic Disorders 2/2018

09.11.2018 | Research Article

Selected RANKL/RANK/OPG system genetic variants in diabetic foot patients

verfasst von: Beata Mrozikiewicz-Rakowska, Piotr Nehring, Konrad Szymański, Agnieszka Sobczyk-Kopcioł, Rafał Płoski, Wojciech Drygas, Janusz Krzymień, Nikita Amit Acharya, Leszek Czupryniak, Adam Przybyłkowski

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Diabetic foot is a complication of long-lasting diabetes mellitus affecting up to 15% of patients, both in type 1 and type 2 diabetes. Osteoprotegerin is involved in osteogenesis and calcification. The aim of the study was to assess the role of selected osteoprotegerin gene variants in diabetes patients with diabetic foot.

Methods

The study involved 300 patients with diabetes and diabetic foot and 968 healthy controls. The study group was formed by 243 patients with diabetic foot of neuropathic origin, 102 with diabetic foot of neuroischemic origin and 77 with Charcot neuroarthropathy.

Results

Compared to controls, rs1872426 and rs1485286 showed correlation with diabetic foot in diabetes subjects. Significant associations between rs2073618, rs1872426, rs7464496 and rs1485286 in men were reported. The aforementioned correlations were also present in type 2 diabetes patient subgroup. Variant rs1485286 was associated to diabetic foot of neuropathic origin. Sex-specificity for females was present for rs6993813 in patients with diabetic foot of neuropathic origin and type 1 diabetes. Variants rs1872426, rs2073617 and rs1485286 were correlated with CN. We found that age, body weight, body mass index, waist circumference, hip circumference and waist-hip ratio were among the basic risk factors of diabetic foot.

Conclusions

The following variants TNFRSF11B (rs2073618, rs2073617, rs1872426, rs1032128, rs7464496, rs11573829 and rs1485286), COLEC10 (rs6993813, rs3134069) and TNFSF11 (rs9533156) present differences in allele frequencies in diabetic foot patients and show correlation with gender, diabetes type and diabetic foot etiology.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Łopatyński J, Mardarowicz G, Nicer T, Szcześniak G, Król H, Matej A, et al. The prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (eastern Poland). Pol Arch Med Wewn. 2001;106:781–6.PubMed Łopatyński J, Mardarowicz G, Nicer T, Szcześniak G, Król H, Matej A, et al. The prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (eastern Poland). Pol Arch Med Wewn. 2001;106:781–6.PubMed
2.
Zurück zum Zitat Abouaesha F, van Schie CH, Griffths GD, et al. Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot. Diabetes Care. 2001;24:1270–4.CrossRefPubMed Abouaesha F, van Schie CH, Griffths GD, et al. Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot. Diabetes Care. 2001;24:1270–4.CrossRefPubMed
3.
Zurück zum Zitat Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis dagger. Ann Med. 2017;49:106–16.CrossRefPubMed Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis dagger. Ann Med. 2017;49:106–16.CrossRefPubMed
4.
Zurück zum Zitat Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45:1085–96.CrossRefPubMed Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45:1085–96.CrossRefPubMed
5.
Zurück zum Zitat Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000;23:796–800.CrossRefPubMed Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000;23:796–800.CrossRefPubMed
7.
Zurück zum Zitat Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med (Berl). 2001;79:243–53.CrossRef Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med (Berl). 2001;79:243–53.CrossRef
8.
Zurück zum Zitat Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89:309–19.CrossRefPubMed Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89:309–19.CrossRefPubMed
9.
Zurück zum Zitat Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93:165–76.CrossRefPubMed Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93:165–76.CrossRefPubMed
10.
Zurück zum Zitat Zdzisinska B, Kandefer-Szerszen M. The role of RANK/RANKL and OPG in multiple myeloma. Postepy Hig Med Dosw (Online). 2006;60:471–82. Zdzisinska B, Kandefer-Szerszen M. The role of RANK/RANKL and OPG in multiple myeloma. Postepy Hig Med Dosw (Online). 2006;60:471–82.
11.
Zurück zum Zitat Molines L, Darmon P, Raccah D. Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab. 2010;36:251–5.CrossRefPubMed Molines L, Darmon P, Raccah D. Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab. 2010;36:251–5.CrossRefPubMed
12.
Zurück zum Zitat Pitocco D, Zelano G, Gioffrè G, et al. Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic Charcot neuroarthropathy: a case-control study. Diabetes Care. 2009;32:1694–7.CrossRefPubMedPubMedCentral Pitocco D, Zelano G, Gioffrè G, et al. Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic Charcot neuroarthropathy: a case-control study. Diabetes Care. 2009;32:1694–7.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Nehring P, Mrozikiewicz-Rakowska B, Sobczyk-Kopciol A, et al. Osteoprotegerin gene rs2073617 and rs3134069 polymorphisms in type 2 diabetes patients and sex-specific rs2073618 polymorphism as a risk factor for diabetic foot. Pol Arch Med Wewn. 2013;123:176–82.PubMed Nehring P, Mrozikiewicz-Rakowska B, Sobczyk-Kopciol A, et al. Osteoprotegerin gene rs2073617 and rs3134069 polymorphisms in type 2 diabetes patients and sex-specific rs2073618 polymorphism as a risk factor for diabetic foot. Pol Arch Med Wewn. 2013;123:176–82.PubMed
14.
Zurück zum Zitat Polakowska M, Piotrowski W. Incidence of diabetes in the polish population: results of the multicenter polish population health status study--WOBASZ. Pol Arch Med Wewn. 2011;121:156–63.PubMed Polakowska M, Piotrowski W. Incidence of diabetes in the polish population: results of the multicenter polish population health status study--WOBASZ. Pol Arch Med Wewn. 2011;121:156–63.PubMed
15.
Zurück zum Zitat Hussain SK, Al-Karawi IN, Sahab KS. Role of Fas/Fas ligand pathway in a sample of Iraq diabetic foot patients. Diyala Journal of Medicine. 2013;5:95–107. Hussain SK, Al-Karawi IN, Sahab KS. Role of Fas/Fas ligand pathway in a sample of Iraq diabetic foot patients. Diyala Journal of Medicine. 2013;5:95–107.
16.
Zurück zum Zitat Guldiken S, Taskiran B, Demir AM, et al. Role of soluble Fas/Fas ligand pathway and Osteoprotegerin in diabetic foot ulceration. ORTADOĞU TIP DERGİSİ. 2013;5:204–9. Guldiken S, Taskiran B, Demir AM, et al. Role of soluble Fas/Fas ligand pathway and Osteoprotegerin in diabetic foot ulceration. ORTADOĞU TIP DERGİSİ. 2013;5:204–9.
17.
Zurück zum Zitat Lajer M, Jorsal A, Tarnow L. Role of osteoprotegerin (OPG) in predicting development of foot ulcer and loss of foot pulse in type 1 diabetic patients with and without diabetic nephropathy. Diabetologia. 2010;53:55–6. Lajer M, Jorsal A, Tarnow L. Role of osteoprotegerin (OPG) in predicting development of foot ulcer and loss of foot pulse in type 1 diabetic patients with and without diabetic nephropathy. Diabetologia. 2010;53:55–6.
18.
Zurück zum Zitat Korzon-Burakowska A, Jakobkiewicz-Banecka J, Fiedosiuk A, et al. Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. Diabet Med. 2012;29:771–5.CrossRefPubMed Korzon-Burakowska A, Jakobkiewicz-Banecka J, Fiedosiuk A, et al. Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. Diabet Med. 2012;29:771–5.CrossRefPubMed
19.
Zurück zum Zitat Jeffcoate WJ, Rasmussen LM, Hofbauer LC, Game FL. Medial arterial calcification in diabetes and its relationship to neuropathy. Diabetologia. 2009;52:2478–88.CrossRefPubMed Jeffcoate WJ, Rasmussen LM, Hofbauer LC, Game FL. Medial arterial calcification in diabetes and its relationship to neuropathy. Diabetologia. 2009;52:2478–88.CrossRefPubMed
20.
Zurück zum Zitat Mrozikiewicz-Rakowska B, Maroszek P, Nehring P, Sobczyk-Kopciol A, Krzyzewska M, Kaszuba AM, et al. Genetic and environmental predictors of chronic kidney disease in patients with type 2 diabetes and diabetic foot ulcer: a pilot study. J Physiol Pharmacol. 2015;66:751–61.PubMed Mrozikiewicz-Rakowska B, Maroszek P, Nehring P, Sobczyk-Kopciol A, Krzyzewska M, Kaszuba AM, et al. Genetic and environmental predictors of chronic kidney disease in patients with type 2 diabetes and diabetic foot ulcer: a pilot study. J Physiol Pharmacol. 2015;66:751–61.PubMed
21.
Zurück zum Zitat Mrozikiewicz-Rakowska B, Lukawska M, Nehring P, et al. Genetic predictors associated with diabetic retinopathy in diabetic foot patients. Pol Arch Med Wew. 2018;128:35–42. Mrozikiewicz-Rakowska B, Lukawska M, Nehring P, et al. Genetic predictors associated with diabetic retinopathy in diabetic foot patients. Pol Arch Med Wew. 2018;128:35–42.
22.
Zurück zum Zitat Genre F, Lopez-Mejias R, Garcia-Bermudez M, et al. Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis. PLoS One. 2014;9:e106823.CrossRefPubMedPubMedCentral Genre F, Lopez-Mejias R, Garcia-Bermudez M, et al. Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis. PLoS One. 2014;9:e106823.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Veyrieras JB, Kudaravalli S, Kim SY, Dermitzakis ET, Gilad Y, Stephens M, et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet. 2008;4:e1000214.CrossRefPubMedPubMedCentral Veyrieras JB, Kudaravalli S, Kim SY, Dermitzakis ET, Gilad Y, Stephens M, et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet. 2008;4:e1000214.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Sheng X, Cai G, Gong X, Yao Z, Zhu Y. Common variants in OPG confer risk to bone mineral density variation and osteoporosis fractures. Sci Rep. 2017;7:1739.CrossRefPubMedPubMedCentral Sheng X, Cai G, Gong X, Yao Z, Zhu Y. Common variants in OPG confer risk to bone mineral density variation and osteoporosis fractures. Sci Rep. 2017;7:1739.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Shang M, Lin L, Cui H. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women. Clin Biochem. 2013;46:1493–501.CrossRefPubMed Shang M, Lin L, Cui H. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women. Clin Biochem. 2013;46:1493–501.CrossRefPubMed
27.
Zurück zum Zitat Yoshida S, Ikari K, Furuya T, Toyama Y, Taniguchi A, Yamanaka H, et al. An osteoprotegerin gene polymorphism is associated with an increased risk of hip fracture in Japanese patients with rheumatoid arthritis: results from the IORRA observational cohort study. PLoS One. 2014;9:e104587.CrossRefPubMedPubMedCentral Yoshida S, Ikari K, Furuya T, Toyama Y, Taniguchi A, Yamanaka H, et al. An osteoprotegerin gene polymorphism is associated with an increased risk of hip fracture in Japanese patients with rheumatoid arthritis: results from the IORRA observational cohort study. PLoS One. 2014;9:e104587.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Li Y, Guo Y, Wang Q, et al. Osteoprotegerin polymorphisms are associated with alcohol-induced osteonecrosis of femoral head in Chinese Han population from Henan province. J Genet. 2016;95:983–9.CrossRefPubMed Li Y, Guo Y, Wang Q, et al. Osteoprotegerin polymorphisms are associated with alcohol-induced osteonecrosis of femoral head in Chinese Han population from Henan province. J Genet. 2016;95:983–9.CrossRefPubMed
29.
Zurück zum Zitat Beyens G, Daroszewska A, de Freitas F, Fransen E, Vanhoenacker F, Verbruggen L, et al. Identification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Paget's disease of bone. J Bone Miner Res. 2007;22:1062–71.CrossRefPubMed Beyens G, Daroszewska A, de Freitas F, Fransen E, Vanhoenacker F, Verbruggen L, et al. Identification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Paget's disease of bone. J Bone Miner Res. 2007;22:1062–71.CrossRefPubMed
30.
Zurück zum Zitat Dong SS, Liu XG, Chen Y, Guo Y, Wang L, Zhao J, et al. Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians. Calcif Tissue Int. 2009;85:104–12.CrossRefPubMedPubMedCentral Dong SS, Liu XG, Chen Y, Guo Y, Wang L, Zhao J, et al. Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians. Calcif Tissue Int. 2009;85:104–12.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010;42:1118–25.CrossRefPubMedPubMedCentral Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010;42:1118–25.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Biscetti F, Giovannini S, Straface G, Bertucci F, Angelini F, Porreca C, et al. RANK/RANKL/OPG pathway: genetic association with history of ischemic stroke in Italian population. Eur Rev Med Pharmacol Sci. 2016;20:4574–80.PubMed Biscetti F, Giovannini S, Straface G, Bertucci F, Angelini F, Porreca C, et al. RANK/RANKL/OPG pathway: genetic association with history of ischemic stroke in Italian population. Eur Rev Med Pharmacol Sci. 2016;20:4574–80.PubMed
33.
Zurück zum Zitat Sassi R, Sahli H, Cheour E, Sellami S, el Gaaied ABA. -643C > T RANKL gene polymorphism is associated with osteoporosis in Tunisian postmenopausal women. Climacteric. 2017;20:374–8.CrossRefPubMed Sassi R, Sahli H, Cheour E, Sellami S, el Gaaied ABA. -643C > T RANKL gene polymorphism is associated with osteoporosis in Tunisian postmenopausal women. Climacteric. 2017;20:374–8.CrossRefPubMed
34.
Zurück zum Zitat Sosenko JM, Gadia MT, Fournier AM, O'Connell MT, Aguiar MC, Skyler JS. Body stature as a risk factor for diabetic sensory neuropathy. Am J Med. 1986;80:1031–4.CrossRefPubMed Sosenko JM, Gadia MT, Fournier AM, O'Connell MT, Aguiar MC, Skyler JS. Body stature as a risk factor for diabetic sensory neuropathy. Am J Med. 1986;80:1031–4.CrossRefPubMed
Metadaten
Titel
Selected RANKL/RANK/OPG system genetic variants in diabetic foot patients
verfasst von
Beata Mrozikiewicz-Rakowska
Piotr Nehring
Konrad Szymański
Agnieszka Sobczyk-Kopcioł
Rafał Płoski
Wojciech Drygas
Janusz Krzymień
Nikita Amit Acharya
Leszek Czupryniak
Adam Przybyłkowski
Publikationsdatum
09.11.2018
Verlag
Springer International Publishing
Erschienen in
Journal of Diabetes & Metabolic Disorders / Ausgabe 2/2018
Elektronische ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-018-0372-4

Weitere Artikel der Ausgabe 2/2018

Journal of Diabetes & Metabolic Disorders 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.